Trial Drug Shows Preliminary Promise Against Ovarian Cancer
SUNDAY, Aug. 21 (HealthDay News) -- An experimental drug that's
shown promise against ovarian cancer caused by mutations in the
BRCA1 or BRCA2 genes may also be effective against ovarian cancer
not caused by those gene mutations, according to a new study.